Form 4 for ABT Abbott Laboratories
Accepted 2026-09-25 17:21:14 ET · period of report 2026-09-23 · accession 0001306119-26-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-25 17:21 | 2026-09-23 | ABT | Conroy Kevin T | Dir | F - Tax | $103.99 | -52.5K | 81.2K | -39% | -$5.46M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2026-09-23 | F | D | 52,507 | $103.99 | 81,230 | D | — | — |